Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates that recruitment has ended for the study, meaning participants can no longer enroll. It also adds new help and guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label from v3.5.5 to v3.6.0, with a minor formatting tweak to the Intervention/Treatment label.SummaryDifference0.5%

- Check18 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page. No study details, outcomes, or eligibility criteria appear to have been changed.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision label updated to v3.5.4, indicating a new version of the page. The change reflects an incremental update to the page metadata rather than substantive content changes.SummaryDifference0.1%

- Check61 days agoChange DetectedUpdated the site’s revision/version indicator from **v3.5.0** to **v3.5.3**, reflecting a maintenance or release update rather than a change to the clinical trial record.SummaryDifference0.1%

- Check97 days agoChange DetectedUpdated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. It appears to be an internal version update and does not alter the study details or page content.SummaryDifference0.1%

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.